SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001206774-17-001397
Filing Date
2017-04-25
Accepted
2017-04-25 16:15:43
Documents
7
Effectiveness Date
2017-04-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS biomarin3208201-defa14a.htm DEFA14A 35388
2 GRAPHIC biomarin3208201-defa14alogo.jpg GRAPHIC 9164
3 GRAPHIC biomarin3208201-defa14ax1x1.jpg GRAPHIC 9082
4 GRAPHIC biomarin3208201-defa14ax1x2.jpg GRAPHIC 2000
5 GRAPHIC biomarin3208201-defa14ax2x1.jpg GRAPHIC 2496
6 GRAPHIC biomarin3208201-defa14ax3x1.jpg GRAPHIC 2013
7 GRAPHIC biomarin3208201-defa14ax4x1.jpg GRAPHIC 2050
  Complete submission text file 0001206774-17-001397.txt   74324
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26727 | Film No.: 17781253
SIC: 2834 Pharmaceutical Preparations